Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II

NCT03123250 is registered in ClinicalTrials.gov with PROCEPT BioRobotics as lead sponsor.

NCT NCT03123250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II
Lead sponsor
PROCEPT BioRobotics
Phase
Not applicable
Overall status
Completed
Start date
August 14, 2017
Completion date
December 20, 2022
Enrollment
101 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia (bph)